Haqq Christopher
SEC insider (Form 3/4/5 filer). CIK 0001612095. Officer at Elicio Therapeutics, Inc. (ELTX). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in BOSTON, MA.
Companies Haqq Christopher has filed insider reports for
- Elicio Therapeutics, Inc. (ELTX): Officer, See Remarks
Haqq Christopher
CIK: 0001612095
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Elicio Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 16, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
64.6K shares- - Feb 2, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirect25.4K shares- - Feb 3, 2025ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
44K shares- - Sep 30, 2024ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
28.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 64,643 | - | - | Direct |
| Feb 2, 2026 | ELTX Elicio Therapeutics, Inc. | Award | 25,400 | - | $0 | Direct |
| Feb 3, 2025 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 44,000 | - | - | Direct |
| Sep 30, 2024 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 28,200 | - | - | Direct |
1-4 of 4 transactions